Application Nr Approved Date Route Status External Links
ANDA078438 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hypertension Trandolapril Tablets Usp Are Indicated For The Treatment Of Hypertension. They May Be Used Alone Or In Combination With Other Antihypertensive Medication Such As Hydrochlorothiazide. Heart Failure Post Myocardial Infarction Or Left-Ventricular Dysfunction Post Myocardial Infarction Trandolapril Tablets Usp Are Indicated In Stable Patients Who Have Evidence Of Left-Ventricular Systolic Dysfunction (Identified By Wall Motion Abnormalities) Or Who Are Symptomatic From Congestive Heart Failure Within The First Few Days After Sustaining Acute Myocardial Infarction. Administration Of Trandolapril To Caucasian Patients Has Been Shown To Decrease The Risk Of Death (Principally Cardiovascular Death) And To Decrease The Risk Of Heart Failure-Related Hospitalization (See Clinical Pharmacology -Heart Failure Or Left-Ventricular Dysfunction Post Myocardial Infarction For Details Of The Survival Trial).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Trandolapril TRANDOLAPRIL ZINC1853205

Comments